Chikungunya News and Research

RSS

Hidden "super spreader" spaces associated with a predominance of asymptomatic cases of dengue

For mosquito-borne diseases such as dengue fever, the abundance of the insects in places where people gather has long served as the main barometer for infection risk.

23 Mar 2023

BioInfect: Bringing the best brains to the challenge of antimicrobial resistance

During the conference, we had the chance to catch up with some of the speakers to ask them about their work, as well as what they would be discussing at the 2023 BioInfet Conference.

6 Mar 2023

Women and girls are disproportionately affected by climate change

The adverse effects of climate change have impacted numerous areas of human health and well-being. In most parts of the world, women are least able to mitigate such changes, so they are an appropriate focus in a recent research paper.

19 Feb 2023

Report of a case of severe tick-borne encephalitis in a pregnant woman

A new study reported a case of severe TBE infection in a pregnant woman, along with long-term sequelae.

16 Feb 2023

How do cattle impact human vector-borne disease risk?

Scientists from the United States have conducted a systematic review to understand whether cattle increase the risk of contracting vector-borne diseases by humans. The review is currently available on the medRxiv* preprint server.

12 Feb 2023

3D architecture ofAedes aegypti’s chromosomes may offer clues on gene expression, regulation

When it comes to DNA, one pesky mosquito turns out to be a rebel among species.

9 Feb 2023

A novel nomenclature system for pathogens like SARS-CoV-2

Researchers develop an automated method to define pathogen lineages in phylogenetic trees.

8 Feb 2023

Modulation of insect immunity to control vector-borne diseases

Discussed the current research on the role of molecular mechanisms in mediating immune priming in insects and regulating vector-borne disease transmission.

19 Dec 2022

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.

9 Dec 2022

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Dr Arturo Reyes Sandoval is the Director of the National Polytechnic Institute, one of the largest and most prestigious universities in Mexico.

7 Dec 2022

Research reveals a novel viral strategy in modulating stress granule formation to promote virus infection

Researchers illustrated a novel strategy likely employed by viruses to promote infection.

6 Dec 2022

Study shows sylvatic origin of chikungunya virus transmission among nonhuman primates of Myanmar

Researchers investigated the potential exposure of peri-urban non-human primates (NHPs) residing near Yangon to arboviruses that have raised health concerns.

22 Nov 2022

NIAID awards more than $12 million for the development of antiviral therapies

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

21 Nov 2022

IVI and Lemonex sign MOU to join forces on vaccine development

The International Vaccine Institute announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development.

10 Nov 2022

Study uncovers a control hub for skin inflammation

Inflammatory reactions in the skin can reduce damage from UV radiation or infections, but can also result in painful symptoms such as sunburn.

2 Nov 2022

Nebulized mRNA-encoded antibodies found to protect hamsters against COVID-19

New research describes a novel route of prevention, using messenger ribonucleic acid (mRNA) molecules that encode protective antibodies within the recipient.

2 Nov 2022

Anthelmintic inhibits exacerbated inflammatory response related to COVID-19 in preclinical research

Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an anthelmintic widely used against tapeworms, effectively inhibits SARS-CoV-2 replication as well as the exacerbated inflammatory response that leads to death in many patients with severe COVID-19.

21 Oct 2022

Review: Arthritogenic alphaviruses and host type I IFN responses

Announcing a new article publication for Zoonoses journal. Arthritogenic alphaviruses, such as Ross River virus, chikungunya virus and O'nyong-nyong virus, cause endemic disease globally and are a major public health concern.

12 Sep 2022

Hand, foot and mouth disease afflicting children hyped up as 'tomato flu'

Leading clinicians and medical researchers in India say they are aghast at the media reports that portray hand, foot and mouth disease (HFMD) — a common, relatively mild, viral infection afflicting children — as caused by a new virus responsible for what is dubbed as 'tomato flu'.

5 Sep 2022

Viruses modify host cellular machinery to produce high amounts of viral progeny

The study, published in Nature Communications, shows a new mechanism whereby viruses modify cellular machinery so that it can better read the instructions in the genome of the invading virus.

29 Aug 2022